Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VeLVET: Vaginal Laser vs Estrogen for GSM
NCT02691936Completed
- Sponsor
- Cleveland Clinic
- Start
- Mar 2016
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Randomised, single-blind trial in genitourinary syndrome of menopause (GSM), sponsored by Cleveland Clinic. Primary endpoint: Vaginal Dryness at 6 months. Started Mar 2016; status: completed.
02
Conditions
genitourinary syndrome of menopause (GSM)
Beyond the preview
Go deeper on NCT02691936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02691936.